✦ LIBER ✦

Randomized Comparison of Four-Times-Daily versus Once-Daily Intravenous Busulfan in Conditioning Therapy for Hematopoietic Cell Transplantation

✍ Scribed by Seong-Gil Ryu; Je-Hwan Lee; Seong-Jun Choi; Jung-Hee Lee; Young-Shin Lee; Miee Seol; Eun-Hye Hur; Soo Han Lee; Kyun Seop Bae; Gyu Jeong Noh; Moo-Song Lee; Sung-Cheol Yun; Sang Beom Han; Kyoo-Hyung Lee

Book ID: 116279699
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 312 KB
Volume: 13
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2007.06.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once daily intravenous busulfan as part

Once daily intravenous busulfan as part of a busulfan/cyclophosphamide conditioning regimen for allogeneic hematopoietic stem cell transplantation

✍ M. Mates; H. Michalska; W. Hasegawa; T. Kiss; A. Daly; D. Loach; H. Messner; J. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Intravenous busulfan dosed four times da

Intravenous busulfan dosed four times daily or once daily as part of the standard BuCy preparative regimen for allogeneic stem cell transplantation

✍ P.J. Shaughnessy; C. Bachier; L. Alexander; B. Bowen; C.F. LeMaistre 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 60 KB

156: Once-daily intravenous busulfan ver

156: Once-daily intravenous busulfan versus oral busulfan in children prior to stem cell transplantation: Study of pharmacokinetics and clinical outcomes

✍ J.J. Boelens; I. Bartelink; R. Bredius; J. Zwaveling; M. Bierings; K. Rademaker; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Once Daily Dose (ODD) Lorazepam (Lo) for

Once Daily Dose (ODD) Lorazepam (Lo) for Seizure Prophylaxis in Conjunction with Once Daily Dose Busulfan (BU) for Pediatric Patients Undergoing Reduced Intensity Conditioning (RIC) for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

✍ M. Shinkle; K. Powers; M. Tobin; M. Kletzel 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Pharmacokinetic and Pharmcodynamic Monit

Pharmacokinetic and Pharmcodynamic Monitoring of Once Daily Intravenous Busulfan in Pediatric Patients Receiving Hematopoietic Stem Cells Transplant: A Single Instutution Experience

✍ J.C. Tse; B. Brown; T.B. Moore 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Pharmacokinetics and Safety of Once-Dail

Pharmacokinetics and Safety of Once-Daily Intravenous Busulfan with Bortezomib in Patients with Relapsed Multiple Myeloma Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation

✍ C.O. Freytes; J.J. Toro; R.F. Yeh; E.A. Stadtmauer; V. Ratanatharathorn; G. Akpe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB